Relationship between Helicobacter pylori infection and gastrointestinal microecology

被引:27
作者
Xu, Wenting [1 ]
Xu, Liming [2 ]
Xu, Chengfu [1 ]
机构
[1] Zhejiang Univ, Affiliated Hosp 1, Dept Gastroenterol, Sch Med, Hangzhou, Peoples R China
[2] Zhejiang Univ, Affiliated Hosp 1, Dept Pathol, Sch Med, Hangzhou, Peoples R China
来源
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY | 2022年 / 12卷
基金
中国国家自然科学基金;
关键词
Helicobacter pylori; gastrointestinal microecology; probiotics; infection; eradication; PROBIOTICS; MICROBIOME; CANCER;
D O I
10.3389/fcimb.2022.938608
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The prevalence of Helicobacter pylori (H. pylori) infection has exceeded 50% worldwide, and it is considered a high-risk factor for chronic gastritis, peptic ulcer, gastric adenocarcinoma, gastroesophageal reflux disease and functional dyspepsia. H. pylori drug resistance is a common problem worldwide. In recent years, the relationship between H. pylori infection and gastrointestinal microecology has received much attention. H. pylori infection changes the structure and composition of gastrointestinal microflora by regulating the gastrointestinal microecological environment, local pH value, cytokines and antimicrobial peptides, and immune response and then plays a crucial role in the occurrence and development of digestive system tumors, liver metabolism and extragastrointestinal diseases. The quadruple strategy of H. pylori eradication can also aggravate gastrointestinal microflora disorder. However, probiotics can reduce intestinal flora changes and imbalances through different mechanisms, thus enhancing the efficacy of H. pylori eradication therapy and reducing adverse reactions caused by eradication therapy. Therefore, this paper reviews the relationship between H. pylori infection and gastrointestinal microecology and its clinical application, providing a basis for clinical treatment.
引用
收藏
页数:11
相关论文
共 81 条
  • [1] Helicobacter pylori infection: How does age influence the inflammatory pattern?
    Araujo, Glauber Rocha Lima
    Marques, Hanna Santos
    Santos, Maria Luisa Cordeiro
    da Silva, Filipe Antonio Franca
    da Brito, Breno Bittencourt
    Correa Santos, Gabriel Lima
    de Melo, Fabricio Freire
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2022, 28 (04) : 402 - 411
  • [2] Enterotypes of the human gut microbiome
    Arumugam, Manimozhiyan
    Raes, Jeroen
    Pelletier, Eric
    Le Paslier, Denis
    Yamada, Takuji
    Mende, Daniel R.
    Fernandes, Gabriel R.
    Tap, Julien
    Bruls, Thomas
    Batto, Jean-Michel
    Bertalan, Marcelo
    Borruel, Natalia
    Casellas, Francesc
    Fernandez, Leyden
    Gautier, Laurent
    Hansen, Torben
    Hattori, Masahira
    Hayashi, Tetsuya
    Kleerebezem, Michiel
    Kurokawa, Ken
    Leclerc, Marion
    Levenez, Florence
    Manichanh, Chaysavanh
    Nielsen, H. Bjorn
    Nielsen, Trine
    Pons, Nicolas
    Poulain, Julie
    Qin, Junjie
    Sicheritz-Ponten, Thomas
    Tims, Sebastian
    Torrents, David
    Ugarte, Edgardo
    Zoetendal, Erwin G.
    Wang, Jun
    Guarner, Francisco
    Pedersen, Oluf
    de Vos, Willem M.
    Brunak, Soren
    Dore, Joel
    Weissenbach, Jean
    Ehrlich, S. Dusko
    Bork, Peer
    [J]. NATURE, 2011, 473 (7346) : 174 - 180
  • [3] Roadmap to eliminate gastric cancer with Helicobacter pylori eradication and consecutive surveillance in Japan
    Asaka, Masahiro
    Kato, Mototsugu
    Sakamoto, Naoya
    [J]. JOURNAL OF GASTROENTEROLOGY, 2014, 49 (01) : 1 - 8
  • [4] Interplay and cooperation of Helicobacter pylori and gut microbiota in gastric carcinogenesis
    Bakhti, Seyedeh Zahra
    Latifi-Navid, Saeid
    [J]. BMC MICROBIOLOGY, 2021, 21 (01)
  • [5] Advancements in the Pharmaceutical Applications of Probiotics: Dosage Forms and Formulation Technology
    Baral, Kshitis Chandra
    Bajracharya, Rajiv
    Lee, Sang Hoon
    Han, Hyo-Kyung
    [J]. INTERNATIONAL JOURNAL OF NANOMEDICINE, 2021, 16 : 7535 - 7556
  • [6] The role of the changing human microbiome in the asthma pandemic
    Borbet, Timothy C.
    Zhang, Xiaozhou
    Mueller, Anne
    Blaser, Martin J.
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2019, 144 (06) : 1457 - 1467
  • [7] Clostridium difficile infection associated with bismuth-based quadruple therapy (Pylere®) for Helicobacter pylori eradication
    Castro-Fernandez, Manuel
    Marques-Ruiz, Alberto
    Camara-Baena, Sergio
    Grande-Santamaria, Lourdes
    [J]. GASTROENTEROLOGIA Y HEPATOLOGIA, 2019, 42 (07): : 459 - 460
  • [8] Role of Probiotics in Prophylaxis of Helicobacter pylori Infection
    Chakravarty, Kashyapi
    Gaur, Smriti
    [J]. CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2019, 20 (02) : 137 - 145
  • [9] The interplay between Helicobacter pylori and gastrointestinal microbiota
    Chen, Chieh-Chang
    Liou, Jyh-Ming
    Lee, Yi-Chia
    Hong, Tzu-Chan
    El-Omar, Emad M.
    Wu, Ming-Shiang
    [J]. GUT MICROBES, 2021, 13 (01) : 1 - 22
  • [10] The efficacy of Lactobacillus acidophilus and rhamnosus in the reduction of bacterial load of Helicobacter pylori and modification of gut microbiota-a double-blind, placebo-controlled, randomized trial
    Chen, Mei-Jyh
    Chen, Chieh-Chang
    Huang, Yu-Chun
    Tseng, Chieh-Chih
    Hsu, Jing-Ting
    Lin, Yi-Fen
    Fang, Yu-Jen
    Wu, Ming-Shiang
    Liou, Jyh-Ming
    [J]. HELICOBACTER, 2021, 26 (06)